U.S. Medical Equipment Stock News

Ameren (AEE) has been active on two fronts, locking in a long dated fixed income deal and speaking to investors at Barclays 40th Annual Energy Power Conference in New York. Recent trading has been choppy for Ameren, with the share price down 5.26% over the past 30 days and 4.39% over 90 days. Yet the year to date share price return of 3.01%, alongside a 1 year total shareholder return of 8.31%, points to steady, income led momentum built over several years, including a 5 year total...

IMAX (IMAX) has delivered a 60.4% total return over the past year. This has put fresh attention on the stock’s recent performance and the US$51.83 closing price as of 16 September 2026. IMAX’s share price has eased slightly in the latest session but still shows strong momentum, with a 16.9% 90-day share price return contributing to a 43.9% year-to-date gain and a 189.7% five-year total shareholder return that points to a long build in investor confidence. Scan beyond IMAX and review a curated...

Semtech has seen its stock price move sharply in recent years, and that kind of run always raises a simple question for investors. Is the current share price broadly in line with what the company actually earns today and is expected to earn in the future? Over the past 3 years the stock has returned about 7x, which puts more pressure on the earnings story to support where the market now values Semtech. Recent product launches around high speed optical connectivity and 10G PON chipsets may...

Pharvaris reported positive topline results from the pivotal Phase 3 CHAPTER-3 trial of once-daily deucrictibant XR, which met its primary and all secondary endpoints for preventing hereditary angioedema attacks across all three HAE types, with an 83% reduction in mean monthly attack rate and a well-tolerated safety profile. The data support Pharvaris’ plan to pursue global marketing applications starting in the first half of 2027. This is intended to anchor a potential oral franchise that...

FedEx launched FedEx Authenticated Delivery, a premium QR code based service for high value and sensitive shipments in the U.S. and Canada that restricts release to authorized recipients and limits delivery changes to protect security. The focus on digital proof of delivery and fraud reduction positions FedEx to deepen relationships in security critical segments such as luxury, healthcare, aerospace, and electronics, where shipping reliability directly affects customer trust and switching...

Synaptics announced that its first CTS module, powered by the SN6012T touch controller and designed for dexterous robotic hands and Physical AI systems, is now supported within NVIDIA Isaac Sim and works with Astra Edge AI processors and NVIDIA Holoscan. The CTS module’s high density 5x12 taxel array, fast rebound sensor design, and native support for NVIDIA’s Newton engine are intended to make Synaptics’ hardware easier to prototype, validate, and integrate into next generation robotics...

Trulieve Cannabis opened a medical cannabis dispensary in Dunwoody, Georgia on 4 September 2026, offering in house brands across capsules, flower, tinctures, topicals, troches and vaporizers. The company is also providing patient education tools such as its Find a Doctor database. This Dunwoody location extends Trulieve Cannabis’s reach into a growing Georgia medical market and adds another outlet for its branded products. It also links retail demand to the company’s online education,...

Carlisle Companies (CSL) has drawn fresh attention after reporting second quarter revenue and EBITDA above analyst expectations, alongside an employee stock option grant tied to its long term value creation plans. Despite the earnings beat, Carlisle Companies’ recent share price momentum has cooled. The stock is down about 10% on a 30‑day share price return and roughly 11% over 90 days, even though the 3‑year total shareholder return of about 29% and 5‑year total shareholder return of about...

Tutor Perini (TPC) is back in focus after reporting record operating cash flow of US$334.1 million for the first half of 2026, along with record quarterly revenue and a near record US$19.9b backlog. The share price tells a different part of the story. Tutor Perini’s stock has eased 6.6% over the past month after a strong run. However, the 90 day share price return of 9.9% and very large 3 year total shareholder return of roughly 10x point to momentum that has been building rather than...

AXT Inc. has seen its share price move sharply in recent years, and the question now is whether the current US$67.75 level can be explained by the revenue the business is generating. With AXT stock heavily in focus, the key issue is how much of that past share price run can be anchored to its sales rather than market excitement alone. AXT has delivered a roughly 28x three year share price return. This places a lot of weight on how much sales can support that kind of change in market...

Wolverine World Wide has seen its share price move in sharply different directions over recent years, which puts a spotlight on whether the current US$19.34 level lines up with the cash flows the business can produce. With investors weighing a mix of gains and setbacks, the question is how today’s valuation stacks up against what Wolverine World Wide’s cash generation can reasonably support. Over the past 3 years, Wolverine World Wide has delivered a total return of about 154%, which raises...

Alkermes (ALKS) has drawn fresh attention after appointing veteran biopharma executive Anne C. Whitaker to its board. The move expands the director group to eleven and adds extensive commercial and operational experience. Alkermes has had a strong run into 2026, with a year to date share price return of 65.29% and a 1 year total shareholder return of 63.61%. However, the 30 day share price return of 5.60% suggests some momentum has cooled, even as the board refresh signals that investors are...

MannKind’s new GLP-1 partnership puts inhaled weight-loss drug in focus MannKind (MNKD) is back in the spotlight after a worldwide licensing and collaboration deal with Rose Pharma to develop ROSE-010 Technosphere, an inhaled GLP-1 candidate for weight management. For investors watching MannKind, the Rose Pharma collaboration lands after a difficult stretch. The share price is down 36.1% year to date, and the 1-year total shareholder return has declined a similar 36.2%, despite a modest 0.9%...

Social Security is back in the headlines, and that puts senior-focused healthcare stocks under a brighter, harsher spotlight. Policy talk on benefit formulas, taxes and long term funding can ripple into how older Americans spend, save and seek care. For investors, that mix of risk and potential reward is hard to ignore. This article walks through three U.S. healthcare stocks tied to senior care and how they intersect with today’s debate. The stocks covered below are just a small sample from...

Copa Holdings (NYSE:CPA) reported preliminary August 2026 traffic figures, with both available seat miles and revenue passenger miles up 16.8% year over year, while the load factor held steady at 88.3%. Copa Holdings shares trade at US$131.05, with a 7.57% year-to-date share price gain and a 16.11% total shareholder return over one year, even though the 90-day share price return declined 13.23%. This suggests that longer-term momentum remains stronger than the recent pullback. Compare Copa...

SLM Corporation has delivered a powerful 3 year share price run, yet the stock has drifted lower over the past year, which puts fresh attention on whether its current price still lines up with the earnings behind it. For anyone considering SLM today, the key issue is how much of the past gains already reflect what the business earns. SLM has climbed 94.5% over the past 3 years, so a lot of the discussion now is about whether that move already bakes in what its profits can reasonably...

Fed rate hikes, stubborn inflation and expensive fuel are squeezing household budgets, which pushes more shoppers toward every discount, coupon and bulk offer they can find. That shift in behavior can help some value focused retailers while leaving others exposed to rising costs. This article examines how that tension plays out and highlights 3 stocks from the screener that appear positioned, for better or worse, in this environment. The three stocks below are just a starting sample. The full...

Exelixis has delivered a strong multi year share price run, and the question now is whether that move lines up with what the company earns today. With the stock recently closing at US$58.49, investors are increasingly asking if the earnings story is doing enough work to support that valuation. Over the past 5 years Exelixis has returned 185.3%, which puts real pressure on the current earnings base to justify where the stock now trades. The recent US FDA review extension for cancer drug...

NVIDIA (NasdaqGS:NVDA) is promoting a "neocloud" model that leans on regional cloud and AI partners rather than only hyperscalers. Recent comments from CEO Jensen Huang outline plans to help finance and coordinate AI data center projects spanning manufacturing, power and infrastructure providers. External industry analysis describes NVIDIA as an emerging "bank of AI" as it arranges capital and partnerships across its wider ecosystem. NVIDIA's push into neocloud infrastructure and AI...

Extreme Networks (EXTR) is putting its agentic AI ambitions into production with the general availability of Extreme Agent ONE Coworker, a subscription add-on now live for Platform ONE customers worldwide. Recent trading has been choppy for Extreme Networks, with the share price up 1.92% over the last day and 5.34% across the past week, yet down 28.90% on a 90 day share price basis and slightly negative on a 1 year total shareholder return. This comes even after a 129.76% total shareholder...

Mercury Systems recently extended Chairman and CEO Bill Ballhaus's employment contract by three years through August 15, 2030, and reaffirmed the financial guidance it issued on its August 2026 earnings call. The move ties leadership continuity directly to the current operating playbook. This signals that Mercury Systems aims to keep execution, backlog quality, and margin mix on the same trajectory that underpinned its recent operational and financial results. We will look at how Mercury...

Amgen reported that the FDA approved a significant update to IMDELLTRA's U.S. prescribing information, reducing the recommended monitoring after the first two infusions to 6 to 8 hours from roughly a full day, while keeping later cycle guidance and safety precautions intact. The shorter monitoring window directly affects real world treatment logistics by potentially easing capacity constraints for community oncology clinics, where most U.S. cancer patients receive care, and lowering...

Recent Price Moves And Business Context For ZTO Express (Cayman) ZTO Express (Cayman) (ZTO) recently closed at US$20.86, with the share price down about 10% over the past month and roughly 5% over the past 3 months. Over the past year the stock has delivered a total return of about 15%. Longer lookback periods such as 3 and 5 years show weaker compounded results for investors who held through that stretch. The logistics provider reports annual revenue of CN¥54,207.651 and net income of...

Reddit has delivered rapid revenue growth and upbeat earnings news, yet the share price is still down sharply over the past year. That mix of strong recent headlines and a weaker stock chart raises a simple question for investors who follow Reddit stock: whether today's market value lines up with what the company currently earns. The share price has fallen 43.5% over the past year, which puts the focus squarely on whether Reddit's earnings profile can support the valuation that...